Tabrecta Капматиниб 200 mg 60 Таб Lucius Indications: Metastatic NSCLC: non-small cell lung cancer with a confirmed skipping mutation in the MET exon 14 gene (METex14). \r\n Dosage: 400 mg (two tablets) twice daily 
Capmatinib, Tabrecta 200 mg 60 tab, generic
In Stock
Indications: Metastatic NSCLC: non-small cell lung cancer with a confirmed skipping mutation in the MET exon 14 gene (METex14).
Dosage: 400 mg (two tablets) twice daily
- Commercial name:Tabrecta
- Сhemical name:Капматиниб
- Dosage:200 mg
- Quantity:60
- Release form:Таб
- Производитель:Lucius
No reviews yet